Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A novel model-based approach for dose determination of glycopyrronium bromide in COPD

  • Helen Arievich1,
  • Tim Overend2Email author,
  • Didier Renard3,
  • Michael Gibbs2,
  • Vijay Alagappan2,
  • Michael Looby3 and
  • Donald Banerji4
BMC Pulmonary Medicine201212:74

DOI: 10.1186/1471-2466-12-74

Received: 23 July 2012

Accepted: 28 November 2012

Published: 8 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Aug 2012 Reviewed Reviewer Report - Alan Kaplan
17 Aug 2012 Reviewed Reviewer Report - Jutta Beier
23 Aug 2012 Reviewed Reviewer Report - Dave Singh
8 Oct 2012 Author responded Author comments - Tim Overend
Resubmission - Version 3
8 Oct 2012 Submitted Manuscript version 3
26 Nov 2012 Reviewed Reviewer Report - Dave Singh
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Nov 2012 Editorially accepted
8 Dec 2012 Article published 10.1186/1471-2466-12-74

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Medars GmbH
(2)
Novartis Horsham Research Centre
(3)
Novartis Pharma AG
(4)
Novartis Pharmaceuticals Corporation

Advertisement